Finally Covaxin Phase 3 results are out in a Pre Print publication
Looks Good, details awaited
Overall efficacy : 77.8 %
Against Delta : 65.2 %
Against severe infections: 93.4%
Asymptomatic infections : 63.6 %
Finally Covaxin Phase 3 results are out in a Pre Print publication
Looks Good, details awaited
Overall efficacy : 77.8 %
Against Delta : 65.2 %
Against severe infections: 93.4%
Asymptomatic infections : 63.6 %
Comments
Post a Comment